| Identification | Back Directory | [Name]
SB234551 | [CAS]
188257-69-4 | [Synonyms]
SB234551
SB234551,CID 5311425
2-[[2-[2-BUTYL-4-[(E)-3-HYDROXY-2-[(6-METHOXY-1,3-BENZODIOXOL-5-YL)METHYL]-3-OXOPROP-1-ENYL]PYRAZOL-3-YL]-5-METHOXYPHENOXY]METHYL]BENZOIC ACID | [Molecular Formula]
C34H34N2O9 | [MOL File]
188257-69-4.mol | [Molecular Weight]
614.65 |
| Hazard Information | Back Directory | [Description]
SB234551 is a novel selective endothelin ETA receptor antagonist. | [Uses]
SB234551 is a selective endothelin ETA receptor antagonist. SB234551 can be used in the study of stroke model[1]. | [References]
[1] Legos JJ, et al. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Exp Neurol. 2008 Jul;212(1):53-62. DOI:10.1016/j.expneurol.2008.03.011 |
|
|